Title | Description |
|---|---|
| Trial ID | KF5503/60 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. |
| Indication | Low back pain, Chronic Pain, Neuropathic Pain |
| UTN | |
| CTG ID | NCT01838616 |
| CTIS ID (former EudraCT) | 2012-002943-11 |
| Trial status | Completed |
| FPI | March 22, 2013 |
| LPO | January 28, 2014 |
| Countries | Austria, Germany, Italy, Spain |
| Gender | All |
| Age | >18 |
| Results | Yes |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.